Navigation Links
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Date:10/27/2008

l contain important information about the proposed merger. The Company's stockholders will be able to obtain, without charge, a copy of the proxy statement (when available) and other relevant documents filed with the SEC from the SEC's website at http://www.sec.gov. The Company's stockholders will also be able to obtain, without charge, a copy of the proxy statement and other relevant documents (when available) by directing a request by mail or telephone to Barr Pharmaceuticals, Inc., 225 Summit Avenue, Montvale, NJ, 07645 - Attention: Investor Relations.

The Company and its directors and officers may be deemed to be participants in the solicitation of proxies from the Company's stockholders with respect to the proposed merger. Information about the Company's directors and executive officers and their ownership of the Company's common stock is set forth in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2007 and the Company's proxy statement for the Company's 2008 Annual Meeting of Stockholders. Stockholders may obtain additional information regarding the interests of the Company and its directors and executive officers in the merger, which may be different than those of the Company's stockholders generally, by reading the proxy statement and other relevant documents regarding the proposed merger, when filed with the SEC.


'/>"/>
SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
2. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
3. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
4. FDA Approves Fougeras Clotrimazole Cream USP 1%
5. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
6. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
7. Signalife Board Approves Merger
8. FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
9. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
10. FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
11. FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
(Date:12/15/2009)... Atomic Force Microscopy (AFM) have been developed and are opening ... liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers to ... viscosity - all in a single force distance curve. ... ... New, constant diameter NeedleProbes are enabling unique measurements ...
(Date:12/15/2009)... Thomson Reuters ... become the first drug pipeline database to fully ... This highly anticipated new content is being provided ... ,, Thomson Pharma will offer ... press releases, conferences, and other sources across all ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ... collaboration with The Scripps Research Institute ("Scripps") by ... the genome of Dyadic,s patented and proprietary C1 ... of the successful relationship between the two organizations ... Scripps to annotate the C1 genome for the ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... - Interim analysis results expected in Q3 ... - Fralex Therapeutics Inc.,(TSX:FXI) ("Fralex" or the ... neuromodulation device, today announced the,randomization of the ... is a,multi-centre, double-blind placebo-controlled randomized clinical trial,designed ...
... CARLSBAD, Calif., March 10 AutoGenomics, a leader ... it,will be among the leading healthcare and biotechnology ... Conference that will be held at the,Boston Marriott ... Chief Executive Officer will present an overview of ...
... Security Administration has awarded a $17 million cooperative agreement ... to develop advanced simulations for commercial and defense applications, ... will focus on the behavior and reliability of miniature ... Excellence chosen by the NNSA. , About 35 researchers ...
Other Biology Technology:Fralex reaches 100th patient milestone in fibromyalgia study 2Fralex reaches 100th patient milestone in fibromyalgia study 3Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4
(Date:12/16/2009)... Calif., Dec. 1 GestureTek Inc. ... Release 3.0 - a turnkey, portable, plug ... advertising, exhibits, entertainment and touring promotions. GestureTek ... of patents in camera-enabled gesture recognition technology ... ,, Guaranteed for quality, the CUBE has ...
(Date:12/16/2009)... Dec. 3 BIO-key International, Inc. ... wireless public safety and finger-based biometric identification ... shareholders at a Special Shareholder Meeting held ... Law Enforcement Division to Interact911 Mobile Systems ... cast in favor and 1.2% were opposed. ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... identification solutions, today announced that SC Magazine, ... publications, named BIO-key International the 2009 Innovator ... sub-category Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ... editor, SC Magazine, "Biometric providers have been ...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 1ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 2ARmark Authentication Technologies LLC and Colorcon Inc Announce Alliance 6078 3Computerized support keeps prominence of name brand drugs at bay 60958 1Computerized support keeps prominence of name brand drugs at bay 60958 2Connection between depression and osteoporosis detailed by Hebrew University researchers 60956 1Connection between depression and osteoporosis detailed by Hebrew University researchers 60956 2
... the growing demand from the public and the scientific ... Press has revised its copyright policy to allow authors ... three journals. The policy, which became effective May 1, ... Journal of Cell Biology, The Journal of Experimental Medicine ...
... into mechanism of action of genes has been hampered by ... This is true for even the most common class of ... signaling events in cells by phosphorylating and modulating the activity ... sequencing efforts that up to a quarter of kinases may ...
... that the device, which he calls a "smarthroscope", may ... unnecessary surgery, and could be useful in developing countries. ... of damage to the tissue surrounding an area affected ... result in cartilage and bone damage. , The instrument ...
Other Biology News:Rockefeller University Press allows authors to retain copyright to their published work 2QUT researchers develop smart instrument for tissue damage assessment 2
... The CHEF-DR III variable angle system, 220-240 V, ... than 6 Mb DNA fragments by pulsed field ... cell, power module, variable-speed pump, 14 x 13 ... holder, 15-well, 1.5 mm thick comb, screened cap, ...
... and filter paper sandwiches are composed of ... sheets of thick filter paper that are ... paper sandwich. These 7 x 8.5 cm ... fit Ready Gel-sized gels and are supplied ...
... fromStreptomyces griseolusthat inhibits protein synthesis. Acts ... eukaryote ribosomes. Reported to induce apoptosis ... promyelocytic leukemia cells, Jurkat cells, ventricular ... intracellular signals and immediate early gene ...
... The RC DC protein assay kit I provides ... concentration in the presence of reducing agents and ... colorimetric assay. The kit includes reagents and standards ... reagent I, 250 ml RC reagent II, 250 ...
Biology Products: